The UK Bioindustry Association (BIA) has been granted permission by the Supreme Court to intervene in its review of Warner-Lambert Company LLC v Generics (UK) Ltd and Actavis. The review will examine the issue of “plausibility” in patent law and could potentially impact the amount of data and evidence required before an invention can be patented. The BIA has intervened in the case to highlight the importance of the issue to the UK’s bioscience sector.
The UK BioIndustry Association (BIA) has today (Thursday 4 January) launched a new guide to help bioscience companies communicate their R&D clearly and effectively to investors and the public.
The guide has been launched as the UK sector prepares to attend one of the world’s largest biotech conferences: the 36th annual JP Morgan Healthcare Conference.
The BioIndustry Association (BIA) has today announced that Parkinson’s UK will be its official Charity of the Year for 2018. The partnership will be formally launched at the upcoming BIA Gala Dinner on 25 January 2018.
The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exit the European Union.
To coincide with today’s House of Commons Health Select Committee on ‘Brexit: the regulation of medicines, medical devices and substances of human origin’, the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have published new research on the public health implications of Brexit.